VentriPoint Diagnostics
Using Artificial Intelligence to create 3D volumetric measurements from standard 2D Echo images for peds and adults.
Launch date
Employees
Market cap
€20.4m
Enterprise valuation
€21m (Public information from Sep 2024)
Share price
CAD0.17 VPT.V
Toronto Ontario (HQ)
Financials
Estimates*
CAD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | <1m | - | <1m | <1m |
% growth | - | 55 % | 35 % | (56 %) | - | - | (28 %) |
EBITDA | (3.7m) | (3.8m) | (3.1m) | (1.6m) | (3.5m) | (4.7m) | (4.7m) |
% EBITDA margin | (9403 %) | (6304 %) | (3865 %) | (4416 %) | - | (6944 %) | (9619 %) |
Profit | (3.7m) | (2.1m) | (3.3m) | (1.9m) | (3.9m) | (4.9m) | (4.9m) |
% profit margin | (9520 %) | (3462 %) | (4101 %) | (5138 %) | - | (7148 %) | (9906 %) |
EV / revenue | 376.1x | 153.7x | 78.0x | 246.5x | - | 551.9x | 922.7x |
EV / EBITDA | -4.0x | -2.4x | -2.0x | -5.6x | -12.6x | -8.0x | -9.6x |
R&D budget | 1.2m | 1.5m | 1.0m | <1m | <1m | 1.1m | 1.1m |
R&D % of revenue | 3031 % | 2409 % | 1289 % | 755 % | - | 1541 % | 2203 % |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $138k | Post IPO Equity | |
N/A | $97.7k | Post IPO Equity | |
N/A | $1.5m | Post IPO Equity | |
N/A | $1.2m | Post IPO Equity | |
N/A | $265k | Post IPO Equity | |
N/A | $748k | Post IPO Debt | |
N/A | $250k | Post IPO Debt | |
N/A | $800k | Post IPO Equity | |
N/A | $600k | Post IPO Equity | |
$160k | Post IPO Debt | ||
$120k | Grant | ||
Total Funding | €109k |
Recent News about VentriPoint Diagnostics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.